Private Wealth Management Group, LLC Neurocrine Biosciences Inc Transaction History
Private Wealth Management Group, LLC
- $253 Billion
- Q3 2024
A detailed history of Private Wealth Management Group, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 27 shares of NBIX stock, worth $3,347. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27
Previous 71
61.97%
Holding current value
$3,347
Previous $9.78 Million
68.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NBIX
# of Institutions
621Shares Held
95.7MCall Options Held
583KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.76 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.25 Billion0.03% of portfolio
-
State Street Corp Boston, MA4.61MShares$571 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.47MShares$306 Million0.6% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.9MShares$235 Million4.37% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...